Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2 - ISAR-DESIRE 2


Although drug-eluting stents (DES) are routinely used for the treatment of in-stent restenosis (ISR), especially those resulting from prior bare-metal stent use, the most effective strategy for the treatment of ISR secondary to DES is unknown. The current trial sought to evaluate the anti-restenotic efficacy of sirolimus-eluting stents (SES) compared with paclitaxel-eluting stents (PES) in the treatment of ISR secondary to SES.